ArticleBMJ open2020

Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trial.

Dimitris Papamargaritis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.